ORACLE-VHT: Preparatory Actions for an EU-HORIZON call on Virtual Human Twins in Cancer – Towards Personalized Management of Pancreatic Cancer
| Reference number | |
| Coordinator | Linköpings universitet |
| Funding from Vinnova | SEK 500 000 |
| Project duration | May 2026 - September 2026 |
| Status | Ongoing |
| Call | Planning grant for international proposal 2026 |
Purpose and goal
The project will prepare a competitive Horizon Europe proposal for ORACLE-VHT, a Virtual Human Twin platform for modeling pancreatic cancer onset and progression, and improvement personalized treatment. The project goals are to consolidate a mulitnational consortium; define concrete work packages, data and governance structures; align the scientific, technical and implementation strategy; and prepare a robust, competitive application ready for submission in September 2026.
Expected effects and result
The immediate result of the planning project is a submission-ready Horizon proposal. Expected longer-term effects are a strengthened, international, multidisciplinary network of clinicians, scientists, industry partners, and patient representatives, working together on accelerated development of clinically useful AI/VHT tools, and advancing scientific knowledge and precision medicine for pancreatic cancer and other highly-lethal and difficult-to-treat malignancies.
Planned approach and implementation
The project will be implemented through coordinated project management, impact/stakeholder analysis, scientific and technical planning, and parallel grant writing. Activities include consortium meetings and workshops, consultation with external advisors and leaders of related Horizon Europe projects, refinement of datasets and methods, definition of roles, milestones and deliverables, ethics/GDPR and data-strategy planning, and integration of partner input into a complete Horizon application.